Hierarchical adaptive and supervisory control of continuous venovenous hemofiltration

Efraín O. Morales, Marios M. Polycarpou, Nat Hemasilpin, John Bissler

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Continuous venovenous hemofiltration (CVVH) is a lifesaving renal replacement therapy used in clinical intensive care settings. Patients undergoing a life threatening illness often develop kidney failure. CVVH performs the blood filtering process while the kidneys recover. Hemofiltration devices which are currently available operate through open-loop fluid flows induced by peristaltic pumps, and possess precisions of ± 30 ml of fluid removed per hour. This precision is inappropriate for a neonate, who can have a total blood volume of only 150 ml, and a 15 ml blood volume reduction could cause hypovolemic shock. Because of the patient risk involved in using such equipment, most medical centers measure the fluid removed from the patient on an hourly basis. This measurement step leads to a signifcant increase in nursing care and therefore increases the cost of the therapy. Presented in this paper is an intelligent CVVH system that deals with accuracy and cost issues while improving the care delivered by timely responding to changes in a patient's cardiovascular state. The intelligence aspect of the system is achieved through a hierarchical control architecture for CVVH. The control methodology uses a direct adaptive control scheme for the peristaltic pumps and a supervisory control algorithm for high-level decisions on the safe operation of the system. Adaptive control of the pumps results in improved accuracy of fluid flow, while the supervisory controller provides greater autonomy which reduces the burden on clinical personnel. The performance of the proposed hierarchical controller is illustrated by experiments on a hemofiltration machine using a simulated patient. These experimental simulations showed that the measured cumulative ultrafiltration after one hour of simulation was only 1.7 ml different from the target value, which is well within the acceptable medical range.

Original languageEnglish (US)
Pages (from-to)445-457
Number of pages13
JournalIEEE Transactions on Control Systems Technology
Volume9
Issue number3
DOIs
StatePublished - May 1 2001

Fingerprint

Blood
Pumps
Flow of fluids
Biomedical equipment
Controllers
Fluids
Nursing
Ultrafiltration
Costs
Personnel
Experiments

All Science Journal Classification (ASJC) codes

  • Control and Systems Engineering
  • Electrical and Electronic Engineering

Cite this

Hierarchical adaptive and supervisory control of continuous venovenous hemofiltration. / Morales, Efraín O.; Polycarpou, Marios M.; Hemasilpin, Nat; Bissler, John.

In: IEEE Transactions on Control Systems Technology, Vol. 9, No. 3, 01.05.2001, p. 445-457.

Research output: Contribution to journalArticle

Morales, Efraín O. ; Polycarpou, Marios M. ; Hemasilpin, Nat ; Bissler, John. / Hierarchical adaptive and supervisory control of continuous venovenous hemofiltration. In: IEEE Transactions on Control Systems Technology. 2001 ; Vol. 9, No. 3. pp. 445-457.
@article{b854630b432f425d96a7ec5174daa9f3,
title = "Hierarchical adaptive and supervisory control of continuous venovenous hemofiltration",
abstract = "Continuous venovenous hemofiltration (CVVH) is a lifesaving renal replacement therapy used in clinical intensive care settings. Patients undergoing a life threatening illness often develop kidney failure. CVVH performs the blood filtering process while the kidneys recover. Hemofiltration devices which are currently available operate through open-loop fluid flows induced by peristaltic pumps, and possess precisions of ± 30 ml of fluid removed per hour. This precision is inappropriate for a neonate, who can have a total blood volume of only 150 ml, and a 15 ml blood volume reduction could cause hypovolemic shock. Because of the patient risk involved in using such equipment, most medical centers measure the fluid removed from the patient on an hourly basis. This measurement step leads to a signifcant increase in nursing care and therefore increases the cost of the therapy. Presented in this paper is an intelligent CVVH system that deals with accuracy and cost issues while improving the care delivered by timely responding to changes in a patient's cardiovascular state. The intelligence aspect of the system is achieved through a hierarchical control architecture for CVVH. The control methodology uses a direct adaptive control scheme for the peristaltic pumps and a supervisory control algorithm for high-level decisions on the safe operation of the system. Adaptive control of the pumps results in improved accuracy of fluid flow, while the supervisory controller provides greater autonomy which reduces the burden on clinical personnel. The performance of the proposed hierarchical controller is illustrated by experiments on a hemofiltration machine using a simulated patient. These experimental simulations showed that the measured cumulative ultrafiltration after one hour of simulation was only 1.7 ml different from the target value, which is well within the acceptable medical range.",
author = "Morales, {Efra{\'i}n O.} and Polycarpou, {Marios M.} and Nat Hemasilpin and John Bissler",
year = "2001",
month = "5",
day = "1",
doi = "10.1109/87.918898",
language = "English (US)",
volume = "9",
pages = "445--457",
journal = "IEEE Transactions on Control Systems Technology",
issn = "1063-6536",
publisher = "Institute of Electrical and Electronics Engineers Inc.",
number = "3",

}

TY - JOUR

T1 - Hierarchical adaptive and supervisory control of continuous venovenous hemofiltration

AU - Morales, Efraín O.

AU - Polycarpou, Marios M.

AU - Hemasilpin, Nat

AU - Bissler, John

PY - 2001/5/1

Y1 - 2001/5/1

N2 - Continuous venovenous hemofiltration (CVVH) is a lifesaving renal replacement therapy used in clinical intensive care settings. Patients undergoing a life threatening illness often develop kidney failure. CVVH performs the blood filtering process while the kidneys recover. Hemofiltration devices which are currently available operate through open-loop fluid flows induced by peristaltic pumps, and possess precisions of ± 30 ml of fluid removed per hour. This precision is inappropriate for a neonate, who can have a total blood volume of only 150 ml, and a 15 ml blood volume reduction could cause hypovolemic shock. Because of the patient risk involved in using such equipment, most medical centers measure the fluid removed from the patient on an hourly basis. This measurement step leads to a signifcant increase in nursing care and therefore increases the cost of the therapy. Presented in this paper is an intelligent CVVH system that deals with accuracy and cost issues while improving the care delivered by timely responding to changes in a patient's cardiovascular state. The intelligence aspect of the system is achieved through a hierarchical control architecture for CVVH. The control methodology uses a direct adaptive control scheme for the peristaltic pumps and a supervisory control algorithm for high-level decisions on the safe operation of the system. Adaptive control of the pumps results in improved accuracy of fluid flow, while the supervisory controller provides greater autonomy which reduces the burden on clinical personnel. The performance of the proposed hierarchical controller is illustrated by experiments on a hemofiltration machine using a simulated patient. These experimental simulations showed that the measured cumulative ultrafiltration after one hour of simulation was only 1.7 ml different from the target value, which is well within the acceptable medical range.

AB - Continuous venovenous hemofiltration (CVVH) is a lifesaving renal replacement therapy used in clinical intensive care settings. Patients undergoing a life threatening illness often develop kidney failure. CVVH performs the blood filtering process while the kidneys recover. Hemofiltration devices which are currently available operate through open-loop fluid flows induced by peristaltic pumps, and possess precisions of ± 30 ml of fluid removed per hour. This precision is inappropriate for a neonate, who can have a total blood volume of only 150 ml, and a 15 ml blood volume reduction could cause hypovolemic shock. Because of the patient risk involved in using such equipment, most medical centers measure the fluid removed from the patient on an hourly basis. This measurement step leads to a signifcant increase in nursing care and therefore increases the cost of the therapy. Presented in this paper is an intelligent CVVH system that deals with accuracy and cost issues while improving the care delivered by timely responding to changes in a patient's cardiovascular state. The intelligence aspect of the system is achieved through a hierarchical control architecture for CVVH. The control methodology uses a direct adaptive control scheme for the peristaltic pumps and a supervisory control algorithm for high-level decisions on the safe operation of the system. Adaptive control of the pumps results in improved accuracy of fluid flow, while the supervisory controller provides greater autonomy which reduces the burden on clinical personnel. The performance of the proposed hierarchical controller is illustrated by experiments on a hemofiltration machine using a simulated patient. These experimental simulations showed that the measured cumulative ultrafiltration after one hour of simulation was only 1.7 ml different from the target value, which is well within the acceptable medical range.

UR - http://www.scopus.com/inward/record.url?scp=0035339021&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035339021&partnerID=8YFLogxK

U2 - 10.1109/87.918898

DO - 10.1109/87.918898

M3 - Article

AN - SCOPUS:0035339021

VL - 9

SP - 445

EP - 457

JO - IEEE Transactions on Control Systems Technology

JF - IEEE Transactions on Control Systems Technology

SN - 1063-6536

IS - 3

ER -